Production of cartilage oligomeric matrix protein (COMP) by cultured human dermal and synovial fibroblasts

George R. Dodge, David Hawkins, Eric Boesler, Lynn Sakai, Sergio A. Jimenez

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Objective: Cartilage oligomeric matrix protein (COMP) is a large disulfide-linked pentameric protein. Each of its five subunits is approximately 100,000 Da in molecular weight. COMP was originally identified and characterized in cartilage and it has been considered a marker of cartilage metabolism because it is currently thought not to be present in other joint tissues, except for tendon. To confirm the tissue specificity of COMP expression we examined cultured human dermal fibroblasts, human foreskin fibroblasts, and normal human synovial cells for the synthesis of COMP in culture. Method: Normal synovial cells and normal human dermal foreskin fibroblasts were isolated from the corresponding tissues by sequential enzymatic digestions and cultured in media containing 10% fetal bovine serum until confluent. During the final 24 h of culture, the cells were labeled with 35S-methionine and 35S-cysteine in serum- and cysteine/methionine- free medium. The newly synthesized COMP molecules were immunoprecipitated from the culture media with a COMP-specific polyclonal antiserum, or with monoclonal antibodies or affinity-purified COMP antibodies. The immunoprecipitated COMP was analyzed by electrophoresis in 5.5% polyacrylamide gels. For other experiments, synovial cells cultured from the synovium of patients with rheumatoid arthritis(RA) and osteoarthritis(OA) were similarly examined. Results: A comparison of the amounts of COMP produced by each cell type (corrected for the DNA content) revealed that synovial cells produced ≥ 9 times more COMP than chondrocytes or dermal fibroblasts. COMP could be easily detected by immunoprecipitation in all cell types. Electrophoretic analysis revealed a distinct band with an apparent MW of 115 120 kDa in samples from each of the three cell types, regardless of the antibody used. COMP expression in cultures of synoviocytes derived from OA and RA patients showed that OA and RA synovial cells produced similar amounts of monomeric COMP of identical size to those COMP monomers produced by normal synovial cells. The addition of TGF-β to these cultures resulted in an increase in COMP production in normal, OA and RA synovial cells (45, 116 and 115% respectively). Conclusion: These studies demonstrate that substantial amounts of COMP are produced by several mesenchymal cells including synoviocytes and dermal fibroblasts. These findings raise important concerns regarding the utility of measurements of COMP levels in serum or in synovial fluid as markers of articular cartilage degradation because of the likelihood that a substantial proportion of COMP or COMP fragments present in serum or synovial fluid may be produced by cells other than articular chondrocytes.

Original languageEnglish (US)
Pages (from-to)435-440
Number of pages6
JournalOsteoarthritis and Cartilage
Volume6
Issue number6
DOIs
StatePublished - Jan 1 1998
Externally publishedYes

Fingerprint

Cartilage Oligomeric Matrix Protein
Cartilage
Fibroblasts
Proteins
Skin
Osteoarthritis
Rheumatoid Arthritis
human COMP protein
Foreskin
Synovial Fluid
Chondrocytes
Serum
Methionine
Tissue
Cysteine
Antibodies
Joints

ASJC Scopus subject areas

  • Rheumatology
  • Biomedical Engineering
  • Orthopedics and Sports Medicine

Cite this

Production of cartilage oligomeric matrix protein (COMP) by cultured human dermal and synovial fibroblasts. / Dodge, George R.; Hawkins, David; Boesler, Eric; Sakai, Lynn; Jimenez, Sergio A.

In: Osteoarthritis and Cartilage, Vol. 6, No. 6, 01.01.1998, p. 435-440.

Research output: Contribution to journalArticle

Dodge, George R. ; Hawkins, David ; Boesler, Eric ; Sakai, Lynn ; Jimenez, Sergio A. / Production of cartilage oligomeric matrix protein (COMP) by cultured human dermal and synovial fibroblasts. In: Osteoarthritis and Cartilage. 1998 ; Vol. 6, No. 6. pp. 435-440.
@article{b0912bfb307c49bab218e17e20569c9d,
title = "Production of cartilage oligomeric matrix protein (COMP) by cultured human dermal and synovial fibroblasts",
abstract = "Objective: Cartilage oligomeric matrix protein (COMP) is a large disulfide-linked pentameric protein. Each of its five subunits is approximately 100,000 Da in molecular weight. COMP was originally identified and characterized in cartilage and it has been considered a marker of cartilage metabolism because it is currently thought not to be present in other joint tissues, except for tendon. To confirm the tissue specificity of COMP expression we examined cultured human dermal fibroblasts, human foreskin fibroblasts, and normal human synovial cells for the synthesis of COMP in culture. Method: Normal synovial cells and normal human dermal foreskin fibroblasts were isolated from the corresponding tissues by sequential enzymatic digestions and cultured in media containing 10{\%} fetal bovine serum until confluent. During the final 24 h of culture, the cells were labeled with 35S-methionine and 35S-cysteine in serum- and cysteine/methionine- free medium. The newly synthesized COMP molecules were immunoprecipitated from the culture media with a COMP-specific polyclonal antiserum, or with monoclonal antibodies or affinity-purified COMP antibodies. The immunoprecipitated COMP was analyzed by electrophoresis in 5.5{\%} polyacrylamide gels. For other experiments, synovial cells cultured from the synovium of patients with rheumatoid arthritis(RA) and osteoarthritis(OA) were similarly examined. Results: A comparison of the amounts of COMP produced by each cell type (corrected for the DNA content) revealed that synovial cells produced ≥ 9 times more COMP than chondrocytes or dermal fibroblasts. COMP could be easily detected by immunoprecipitation in all cell types. Electrophoretic analysis revealed a distinct band with an apparent MW of 115 120 kDa in samples from each of the three cell types, regardless of the antibody used. COMP expression in cultures of synoviocytes derived from OA and RA patients showed that OA and RA synovial cells produced similar amounts of monomeric COMP of identical size to those COMP monomers produced by normal synovial cells. The addition of TGF-β to these cultures resulted in an increase in COMP production in normal, OA and RA synovial cells (45, 116 and 115{\%} respectively). Conclusion: These studies demonstrate that substantial amounts of COMP are produced by several mesenchymal cells including synoviocytes and dermal fibroblasts. These findings raise important concerns regarding the utility of measurements of COMP levels in serum or in synovial fluid as markers of articular cartilage degradation because of the likelihood that a substantial proportion of COMP or COMP fragments present in serum or synovial fluid may be produced by cells other than articular chondrocytes.",
author = "Dodge, {George R.} and David Hawkins and Eric Boesler and Lynn Sakai and Jimenez, {Sergio A.}",
year = "1998",
month = "1",
day = "1",
doi = "10.1053/joca.1998.0147",
language = "English (US)",
volume = "6",
pages = "435--440",
journal = "Osteoarthritis and Cartilage",
issn = "1063-4584",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Production of cartilage oligomeric matrix protein (COMP) by cultured human dermal and synovial fibroblasts

AU - Dodge, George R.

AU - Hawkins, David

AU - Boesler, Eric

AU - Sakai, Lynn

AU - Jimenez, Sergio A.

PY - 1998/1/1

Y1 - 1998/1/1

N2 - Objective: Cartilage oligomeric matrix protein (COMP) is a large disulfide-linked pentameric protein. Each of its five subunits is approximately 100,000 Da in molecular weight. COMP was originally identified and characterized in cartilage and it has been considered a marker of cartilage metabolism because it is currently thought not to be present in other joint tissues, except for tendon. To confirm the tissue specificity of COMP expression we examined cultured human dermal fibroblasts, human foreskin fibroblasts, and normal human synovial cells for the synthesis of COMP in culture. Method: Normal synovial cells and normal human dermal foreskin fibroblasts were isolated from the corresponding tissues by sequential enzymatic digestions and cultured in media containing 10% fetal bovine serum until confluent. During the final 24 h of culture, the cells were labeled with 35S-methionine and 35S-cysteine in serum- and cysteine/methionine- free medium. The newly synthesized COMP molecules were immunoprecipitated from the culture media with a COMP-specific polyclonal antiserum, or with monoclonal antibodies or affinity-purified COMP antibodies. The immunoprecipitated COMP was analyzed by electrophoresis in 5.5% polyacrylamide gels. For other experiments, synovial cells cultured from the synovium of patients with rheumatoid arthritis(RA) and osteoarthritis(OA) were similarly examined. Results: A comparison of the amounts of COMP produced by each cell type (corrected for the DNA content) revealed that synovial cells produced ≥ 9 times more COMP than chondrocytes or dermal fibroblasts. COMP could be easily detected by immunoprecipitation in all cell types. Electrophoretic analysis revealed a distinct band with an apparent MW of 115 120 kDa in samples from each of the three cell types, regardless of the antibody used. COMP expression in cultures of synoviocytes derived from OA and RA patients showed that OA and RA synovial cells produced similar amounts of monomeric COMP of identical size to those COMP monomers produced by normal synovial cells. The addition of TGF-β to these cultures resulted in an increase in COMP production in normal, OA and RA synovial cells (45, 116 and 115% respectively). Conclusion: These studies demonstrate that substantial amounts of COMP are produced by several mesenchymal cells including synoviocytes and dermal fibroblasts. These findings raise important concerns regarding the utility of measurements of COMP levels in serum or in synovial fluid as markers of articular cartilage degradation because of the likelihood that a substantial proportion of COMP or COMP fragments present in serum or synovial fluid may be produced by cells other than articular chondrocytes.

AB - Objective: Cartilage oligomeric matrix protein (COMP) is a large disulfide-linked pentameric protein. Each of its five subunits is approximately 100,000 Da in molecular weight. COMP was originally identified and characterized in cartilage and it has been considered a marker of cartilage metabolism because it is currently thought not to be present in other joint tissues, except for tendon. To confirm the tissue specificity of COMP expression we examined cultured human dermal fibroblasts, human foreskin fibroblasts, and normal human synovial cells for the synthesis of COMP in culture. Method: Normal synovial cells and normal human dermal foreskin fibroblasts were isolated from the corresponding tissues by sequential enzymatic digestions and cultured in media containing 10% fetal bovine serum until confluent. During the final 24 h of culture, the cells were labeled with 35S-methionine and 35S-cysteine in serum- and cysteine/methionine- free medium. The newly synthesized COMP molecules were immunoprecipitated from the culture media with a COMP-specific polyclonal antiserum, or with monoclonal antibodies or affinity-purified COMP antibodies. The immunoprecipitated COMP was analyzed by electrophoresis in 5.5% polyacrylamide gels. For other experiments, synovial cells cultured from the synovium of patients with rheumatoid arthritis(RA) and osteoarthritis(OA) were similarly examined. Results: A comparison of the amounts of COMP produced by each cell type (corrected for the DNA content) revealed that synovial cells produced ≥ 9 times more COMP than chondrocytes or dermal fibroblasts. COMP could be easily detected by immunoprecipitation in all cell types. Electrophoretic analysis revealed a distinct band with an apparent MW of 115 120 kDa in samples from each of the three cell types, regardless of the antibody used. COMP expression in cultures of synoviocytes derived from OA and RA patients showed that OA and RA synovial cells produced similar amounts of monomeric COMP of identical size to those COMP monomers produced by normal synovial cells. The addition of TGF-β to these cultures resulted in an increase in COMP production in normal, OA and RA synovial cells (45, 116 and 115% respectively). Conclusion: These studies demonstrate that substantial amounts of COMP are produced by several mesenchymal cells including synoviocytes and dermal fibroblasts. These findings raise important concerns regarding the utility of measurements of COMP levels in serum or in synovial fluid as markers of articular cartilage degradation because of the likelihood that a substantial proportion of COMP or COMP fragments present in serum or synovial fluid may be produced by cells other than articular chondrocytes.

UR - http://www.scopus.com/inward/record.url?scp=0032213648&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032213648&partnerID=8YFLogxK

U2 - 10.1053/joca.1998.0147

DO - 10.1053/joca.1998.0147

M3 - Article

VL - 6

SP - 435

EP - 440

JO - Osteoarthritis and Cartilage

JF - Osteoarthritis and Cartilage

SN - 1063-4584

IS - 6

ER -